TAVIRA, PORTUGAL – November 25, 2024 — Gro-Vida, a leading medical cannabis cultivator based in Portugal’s Algarve region, has announced a landmark supply agreement with Canopy Growth Germany GmbH, the German subsidiary of global cannabis giant Canopy Growth Corporation. This collaboration aims to meet the growing demand for medicinal cannabis in Germany, marking a strategic move to supply EU-based cannabis as part of Canopy Growth’s international expansion.
Strengthening the EU Supply Chain
The agreement will see Gro-Vida supply EU-GMP-certified medicinal cannabis flowers to Canopy Growth Germany, which will distribute them under its renowned Tweed brand. This partnership is particularly significant as it enhances Canopy Growth’s supply chain diversification, complementing its existing Canadian-based GMP (Good Manufacturing Practices) production with premium-quality cannabis sourced from Portugal.
Mallory Bodnar, Managing Director at Gro-Vida, expressed her excitement: “It is a remarkable honor to have a global leader recognize the exceptional quality of cannabis produced here in Portugal. This partnership is a testament to the promising future of Portuguese-grown cannabis on the world stage.”
Expanding Access in Germany
Under the agreement, Gro-Vida will cultivate a range of medicinal cannabis strains specifically tailored for Canopy Growth GmbH, aiming to meet the needs of Germany’s rapidly expanding medicinal cannabis market. Products will be available to patients through prescriptions from their healthcare practitioners starting in Q1 2025.
This collaboration represents a key milestone for both companies, with Tara Rozalowsky, Chief Growth Officer and President, International at Canopy Growth, emphasizing the strategic importance of sourcing EU-based cannabis: “Sourcing EU-GMP flower from Portugal, alongside our EU-GMP Canadian-grown cannabis, allows us to offer a versatile and competitive product portfolio in the German market.”
The Growing Medicinal Cannabis Market in Germany
Germany has one of the most progressive medicinal cannabis programs in Europe, with demand for prescribed cannabis products steadily increasing. This supply agreement positions both Gro-Vida and Canopy Growth GmbH to tap into this growing market, offering high-quality cannabis products to patients nationwide.
Key Highlights of the Agreement:
- Gro-Vida will provide EU-GMP-certified cannabis flowers for Canopy Growth.
- Products will be sold under Tweed, a trusted global cannabis brand.
- The cannabis will be available to German patients starting Q1 2025.
- This partnership bolsters Canopy Growth’s asset light strategy by sourcing from multiple EU locations.
This collaboration between Gro-Vida and Canopy Growth GmbH signifies a significant step toward meeting the increasing demand for medicinal cannabis in Europe while ensuring high standards of quality and supply chain diversification.
